GLP-1 Receptor Agonist Randomized Trial Results: MACE and Kidney Protection
GLP-1 Clinical Relevance #38Contextual Information Background context; limited direct clinical applicability. ⚕ GLP-1 News | CED Clinic Clinical TrialTarget Trial EmulationType 1 DiabetesSemaglutideEndocrinologyAdults With Type 1…
GLP-1 Receptor Agonist Safety: Pancreatitis Risk in Type 1 Diabetes
GLP-1 Clinical Relevance #41Contextual Information Background context; limited direct clinical applicability. ⚕ GLP-1 News | CED Clinic CommentaryObservational StudyType 1 DiabetesGLP-1 Receptor AgonistEndocrinologyAdults with…
GLP-1 Receptor Agonists: Type 1 Diabetes End-Organ Protection
GLP-1 Clinical Relevance #42Contextual Information Background context; limited direct clinical applicability. ⚕ GLP-1 News | CED Clinic Clinical TrialRandomized Controlled TrialType 1 DiabetesGLP-1 Receptor…
GLP-1 Receptor Agonists in Type 1 Diabetes: Clinical Evidence
GLP-1 Clinical Relevance #43Contextual Information Background context; limited direct clinical applicability. ⚕ GLP-1 News | CED Clinic Clinical CommentaryType 1 DiabetesGLP-1 Receptor AgonistEndocrinologyAdult PatientsGlycemic…
GLP-1 Receptor Agonists Type 1 Diabetes
GLP-1 Clinical Relevance #52Moderate Clinical Relevance Relevant context for GLP-1 prescribers; interpret with care. ⚕ GLP-1 News | CED Clinic Clinical CommentaryType 1 DiabetesGLP-1 Receptor AgonistSemaglutideEndocrinologyAdults…
